Ohio State Fair victim dies of liver failure year after thrill ride accident
COLUMBUS, Ohio – 19-year-old woman has died just over a year after she suffered a traumatic brain injury in a thrill ride accident at last year’s Ohio State Fair. An…
by October Gallery
COLUMBUS, Ohio – 19-year-old woman has died just over a year after she suffered a traumatic brain injury in a thrill ride accident at last year’s Ohio State Fair. An…
FRANKFURT (Reuters) – Merck KGaA said that its immunotherapy Bavencio, jointly developed with Pfizer, delayed the progression of kidney cancer when used in combination with Pfizer’s Inlyta drug in a…
A British ultra-marathoner is getting kudos from athletes and parents around the world after photos of her breastfeeding her 3-month-old while pumping during a rest stop 16 hours into the…
BENI, Democratic Republic of Congo (Reuters) – When Esperance Nzavaki heard she was cured of Ebola after three weeks of cutting-edge care at a medical center in eastern Democratic Republic…
Seltzer water can be a wonderful way to stay hydrated — especially if you’re not in the mood for regular water. (iStock) Seltzer water seems to be making a bit…
CHICAGO (Reuters) – Two major health scares at U.S. airports involving inbound flights are related to pilgrims returning from the Hajj, the Muslim pilgrimage to the holy city of Mecca,…
Hospitals are particularly hard hit and frequently must scramble to find scarce medicines, often at huge price markups, or come up with workarounds that may not be as effective or…
SEOUL (Reuters) – A South Korean man, 61, was diagnosed with the potentially deadly Middle East Respiratory Syndrome (MERS) and is being treated at a hospital in Seoul, the Korea…
Most common back-to-school illnesses Most kids around the U.S. are back in school and that means reading, writing-and germs. Fox News’ Dr. Manny Alvarez sits down with New York City…
(Reuters) – Akcea Therapeutics Inc said on Thursday it planned to cut its workforce by about 10 percent after the U.S. health regulator declined to approve its Waylivra drug for…